Kelyniam Global, Inc. Stock Other OTC
Equities
KLYG
US4883591004
Advanced Medical Equipment & Technology
Financials (USD)
Sales 2022 | 3.02M | Sales 2023 | 2.67M | Capitalization | 1.83M |
---|---|---|---|---|---|
Net income 2022 | - | Net income 2023 | - | EV / Sales 2022 | 0.99 x |
Net Debt 2022 | 560K | Net Debt 2023 | 623K | EV / Sales 2023 | 0.92 x |
P/E ratio 2022 |
-24.8
x | P/E ratio 2023 |
-8.35
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 53.55% |
Managers | Title | Age | Since |
---|---|---|---|
Ross Bjella
CEO | Chief Executive Officer | - | 18-01-08 |
Director of Finance/CFO | - | 20-01-31 | |
Chief Operating Officer | - | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Operating Officer | - | 10-12-31 | |
Mark V. Smith
PRN | Corporate Officer/Principal | - | 14-05-31 |
Ross Bjella
CEO | Chief Executive Officer | - | 18-01-08 |
1st Jan change | Capi. | |
---|---|---|
+8.78% | 220B | |
+8.24% | 185B | |
+11.16% | 133B | |
+26.12% | 107B | |
+0.30% | 62.91B | |
+16.21% | 53.34B | |
-1.63% | 47.71B | |
-1.11% | 40.29B | |
+12.16% | 39.57B |